US 12,268,721 B2
Botanical formulations
Michelle Hines, Hickory Creek, TX (US); and Tiffany Carle, Dallas, TX (US)
Assigned to MARY KAY INC., Addison, TX (US)
Filed by Mary Kay Inc., Addison, TX (US)
Filed on Dec. 13, 2023, as Appl. No. 18/538,812.
Application 18/538,812 is a continuation of application No. 18/123,711, filed on Mar. 20, 2023, abandoned.
Application 18/123,711 is a continuation of application No. 17/173,746, filed on Feb. 11, 2021, granted, now 11,638,735, issued on May 2, 2023.
Application 17/173,746 is a continuation of application No. 16/260,875, filed on Jan. 29, 2019, granted, now 10,953,058, issued on Mar. 23, 2021.
Application 16/260,875 is a continuation of application No. 15/388,541, filed on Dec. 22, 2016, granted, now 10,682,381, issued on Jun. 16, 2020.
Application 15/388,541 is a continuation of application No. 14/266,382, filed on Apr. 30, 2014, granted, now 9,561,198, issued on Feb. 7, 2017.
Application 14/266,382 is a continuation of application No. 13/907,500, filed on May 31, 2013, granted, now 8,747,926, issued on Jun. 10, 2014.
Application 13/907,500 is a continuation of application No. 13/326,138, filed on Dec. 14, 2011, granted, now 8,481,090, issued on Jul. 9, 2013.
Application 13/326,138 is a continuation of application No. 12/768,450, filed on Apr. 27, 2010, granted, now 8,440,237, issued on May 14, 2013.
Claims priority of provisional application 61/173,042, filed on Apr. 27, 2009.
Prior Publication US 2024/0108673 A1, Apr. 4, 2024
Int. Cl. A61K 36/00 (2006.01); A61K 8/97 (2017.01); A61K 8/9706 (2017.01); A61K 8/9711 (2017.01); A61K 8/9728 (2017.01); A61K 8/9767 (2017.01); A61K 8/9789 (2017.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/107 (2006.01); A61K 31/192 (2006.01); A61K 31/202 (2006.01); A61K 31/235 (2006.01); A61K 31/60 (2006.01); A61K 36/03 (2006.01); A61K 36/185 (2006.01); A61K 36/28 (2006.01); A61K 36/48 (2006.01); A61K 36/61 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/20 (2006.01); A61Q 19/00 (2006.01)
CPC A61K 36/28 (2013.01) [A61K 8/97 (2013.01); A61K 8/9706 (2017.08); A61K 8/9711 (2017.08); A61K 8/9728 (2017.08); A61K 8/9767 (2017.08); A61K 8/9789 (2017.08); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/107 (2013.01); A61K 31/192 (2013.01); A61K 31/202 (2013.01); A61K 31/235 (2013.01); A61K 31/60 (2013.01); A61K 36/03 (2013.01); A61K 36/185 (2013.01); A61K 36/48 (2013.01); A61K 36/61 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/186 (2013.01); A61K 47/20 (2013.01); A61Q 19/00 (2013.01)] 8 Claims
 
1. A method of treating acne comprising topically applying to skin in need thereof a composition comprising:
(a) Epilobium angustifolium extract; and
(b) Cystoseira amentacea and/or Caespitosa brachycarpa extract; and
(c) comprises salicylic acid, benzoyl peroxide, benzoic acid, and/or tretinoin.